Vinblastinsulfat Teva® 1 mg/ml Injektionslösung

DRUG2 trials

Sponsors

Takeda Development Center Americas Inc., Universitaetsklinikum Heidelberg AöR

Conditions

Advanced Classical Hodgkin Lymphomaprogressive/relapsed/refractory pediatric low-grade glioma (pLGG)

Phase 1

Phase I/II combination umbrella trial in progressive/relapsed/refractory pediatric low-grade glioma (pLGG) (EPILOGUE)

Not yet recruitingCTIS2024-516896-34-00

Universitaetsklinikum Heidelberg AöRprogressive/relapsed/refractory pediatric low-grade glioma (pLGG)

Target: 28Updated: 2026-03-18

Phase 3

A Randomized, Open-label, Phase 3 Trial of A+AVD Versus ABVD as Frontline Therapy in Patients With Advanced Classical Hodgkin Lymphoma

Active, not recruitingCTIS2023-506419-16-00

Takeda Development Center Americas Inc.Advanced Classical Hodgkin Lymphoma

Start: 2013-01-08Target: 448Updated: 2025-12-15